Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)
Viroj Wiwanitkit1–31Wiwanitkit House, Bang Khae, Bangkok, Thailand; 2Hainan Medical University, Haikou, Hainan, People's Republic of China; 3Joseph Ayo Babalola University, Ikeji-Arakeji, Osun State, NigeriaAbstract: Leishmaniasis is an important vector-borne disease, and i...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-06-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Online Access: | http://www.dovepress.com/interest-in-paromomycin-for-the-treatment-of-visceral-leishmaniasis-ka-a10203 |
| _version_ | 1818725046402678784 |
|---|---|
| author | Wiwanitkit V |
| author_facet | Wiwanitkit V |
| author_sort | Wiwanitkit V |
| collection | DOAJ |
| description | Viroj Wiwanitkit1–31Wiwanitkit House, Bang Khae, Bangkok, Thailand; 2Hainan Medical University, Haikou, Hainan, People's Republic of China; 3Joseph Ayo Babalola University, Ikeji-Arakeji, Osun State, NigeriaAbstract: Leishmaniasis is an important vector-borne disease, and it is classified as one of the most important tropical fly-borne infections. This disease can cause two types of clinical manifestations: cutaneous forms and visceral forms. Visceral leishmaniasis, which is also called kala-azar, is a very serious infection that can be fatal. The management of visceral leishmaniasis requires informed diagnostic and therapeutic approaches. Continuous research and development regarding the treatment of visceral leishmaniasis had led to many improvements. Paromomycin is a relatively new antibiotic drug that has been used for the treatment of visceral leishmaniasis for several years. This article reviews and discusses the use of paromomycin for visceral leishmaniasis therapy.Keywords: visceral, leishmaniasis, paromomycin |
| first_indexed | 2024-12-17T21:36:05Z |
| format | Article |
| id | doaj.art-083e4e9521e94bd480365b23b9820921 |
| institution | Directory Open Access Journal |
| issn | 1176-6336 1178-203X |
| language | English |
| last_indexed | 2024-12-17T21:36:05Z |
| publishDate | 2012-06-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Therapeutics and Clinical Risk Management |
| spelling | doaj.art-083e4e9521e94bd480365b23b98209212022-12-21T21:31:44ZengDove Medical PressTherapeutics and Clinical Risk Management1176-63361178-203X2012-06-012012default323328Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)Wiwanitkit VViroj Wiwanitkit1–31Wiwanitkit House, Bang Khae, Bangkok, Thailand; 2Hainan Medical University, Haikou, Hainan, People's Republic of China; 3Joseph Ayo Babalola University, Ikeji-Arakeji, Osun State, NigeriaAbstract: Leishmaniasis is an important vector-borne disease, and it is classified as one of the most important tropical fly-borne infections. This disease can cause two types of clinical manifestations: cutaneous forms and visceral forms. Visceral leishmaniasis, which is also called kala-azar, is a very serious infection that can be fatal. The management of visceral leishmaniasis requires informed diagnostic and therapeutic approaches. Continuous research and development regarding the treatment of visceral leishmaniasis had led to many improvements. Paromomycin is a relatively new antibiotic drug that has been used for the treatment of visceral leishmaniasis for several years. This article reviews and discusses the use of paromomycin for visceral leishmaniasis therapy.Keywords: visceral, leishmaniasis, paromomycinhttp://www.dovepress.com/interest-in-paromomycin-for-the-treatment-of-visceral-leishmaniasis-ka-a10203 |
| spellingShingle | Wiwanitkit V Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar) Therapeutics and Clinical Risk Management |
| title | Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar) |
| title_full | Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar) |
| title_fullStr | Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar) |
| title_full_unstemmed | Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar) |
| title_short | Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar) |
| title_sort | interest in paromomycin for the treatment of visceral leishmaniasis kala azar |
| url | http://www.dovepress.com/interest-in-paromomycin-for-the-treatment-of-visceral-leishmaniasis-ka-a10203 |
| work_keys_str_mv | AT wiwanitkitv interestinparomomycinforthetreatmentofvisceralleishmaniasiskalaazar |